Trial intelligence / Profile preview

Pharmacogenomics of mood stabilizer response in bipolar disorder

2010-023740-32Phase 4Completed

Sponsor
Haukeland University Hospital
Start
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of lithium sulfate and Sodium valproate + valproic acid in bipolar disorder (BD) (3 arms), sponsored by Haukeland University Hospital. Primary endpoints: Relapse, Manic relapse and 2 more. Started Mar 2011; status: completed.

02

Drugs

lithium sulfateSodium valproate + valproic acid
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on 2010-023740-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023740-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call